Competitive Technologies, Inc. (OTCQX: CTTC), based in Fairfield, CT, is a global leader in identifying, developing, and commercializing innovative products and technologies in life, electronic, nano, and physical sciences developed by universities, companies and inventors. CTTC provides distribution, patent and technology transfer, selling and licensing services. It focuses on customer needs and matches those needs with commercially viable technology or product solutions provided by its clients.

CTTC has worldwide exclusive rights to a non-invasive pain management therapy device for rapid treatment of high-intensity oncologic and neuropathic pain, including pain resistant to morphine and other drugs. Developed in Italy by CTTC’s client, Prof. Giuseppe Marineo, the technology was brought to CTTC through the efforts of Prof. Giancarlo Elia Valori of the Italian business development group, Sviluppo Lazio S.p.A.

The multiprocessor apparatus is designed to simultaneously treat multiple pain areas by means of single-use surface electrodes applied to the skin area corresponding to the pain. Calmare has successfully treated over 3,000 patients in the U.S. and Europe.

CTTC licensee GEOMC of Korea is manufacturing the device commercially for worldwide sales. Individual country-exclusive distribution agreements have been signed for India, Korea, Bangladesh and Malaysia. CTTC also has signed a distribution agreement for 31 countries throughout Europe, Asia, Africa, South America, Middle East and Oceania.